4.6 Article

Guanine-Rich Sequences Are a Dominant Feature of Exosomal microRNAs across the Mammalian Species and Cell Types

期刊

PLOS ONE
卷 11, 期 4, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0154134

关键词

-

资金

  1. Ministry of Education, Culture, Sports, Science and Technology of Japan [24800033]
  2. Exploratory Research for Advanced Technology of Japan Science and Technology Agency (ERATO Akiyoshi Bio-nanotransporter Project, JST)
  3. Grants-in-Aid for Scientific Research [24800033] Funding Source: KAKEN

向作者/读者索取更多资源

Exosome is an extracellular vesicle released from multivesicular endosomes and contains micro (mi) RNAs and functional proteins derived from the donor cells. Exosomal miRNAs act as an effector during communication with appropriate recipient cells, this can aid in the utilization of the exosomes in a drug delivery system for various disorders including malignancies. Differences in the miRNA distribution pattern between exosomes and donor cells indicate the active translocation of miRNAs into the exosome cargos in a miRNA sequence-dependent manner, although the molecular mechanism is little known. In this study, we statistically analyzed the miRNA microarray data and revealed that the guanine (G)-rich sequence is a dominant feature of exosome-dominant miRNAs, across the mammalian species-specificity and the cell types. Our results provide important information regarding the potential use of exosome cargos to develop miRNA-based drugs for the treatment of human diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, Research & Experimental

Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance

Daisuke Muraoka, Naohiro Seo, Tae Hayashi, Yoshiro Tahara, Keisuke Fujii, Isao Tawara, Yoshihiro Miyahara, Kana Okamori, Hideo Yagita, Seiya Imoto, Rui Yamaguchi, Mitsuhiro Komura, Satoru Miyano, Masahiro Goto, Shin-ichi Sawada, Akira Asai, Hiroaki Ikeda, Kazunari Akiyoshi, Naozumi Harada, Hiroshi Shiku

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Oncology

Immunohistochemical expression and clinicopathological assessment of the cancer testis antigens NY-ESO-1 and MAGE-A4 in high-grade soft-tissue sarcoma

Takuya Kakimoto, Akihiko Matsumine, Shinichi Kageyama, Kunihiro Asanuma, Takao Matsubara, Tomoki Nakamura, Takahiro Iino, Hiroaki Ikeda, Hiroshi Shiku, Akihiro Sudo

ONCOLOGY LETTERS (2019)

Article Oncology

Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells

Wenjie Gong, Jean-Marc Hoffmann, Sophia Stock, Lei Wang, Yibin Liu, Maria-Luisa Schubert, Brigitte Neuber, Angela Hueckelhoven-Krauss, Ulrike Gern, Anita Schmitt, Carsten Mueller-Tidow, Hiroshi Shiku, Michael Schmitt, Leopold Sellner

CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)

Article Oncology

First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors

Mikiya Ishihara, Yasutaka Tono, Yoshihiro Miyahara, Daisuke Muraoka, Naozumi Harada, Shinichi Kageyama, Takeshi Sasaki, Yasuhide Hori, Norihito Soga, Katsunori Uchida, Taizo Shiraishi, Eiichi Sato, Hideki Kanda, Toshiro Mizuno, Gill A. Webster, Hiroaki Ikeda, Naoyuki Katayama, Yoshiki Sugimura, Hiroshi Shiku

CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)

Article Cell Biology

Development of INSOL-tag for proteome-wide protein handling and its application in protein array analysis

Eriko Fukuda, Masatoshi Mori, Hiroshi Shiku, Yoshihiro Miyahara, Yoshifumi Kawamura, Koji Ogawa, Toshihiko Ogura, Naoki Goshima

GENES TO CELLS (2020)

Article Hematology

Development of a Unique T Cell Receptor Gene-Transferred Tax-Redirected T Cell Immunotherapy for Adult T Cell Leukemia

Koji Kawamura, Yukie Tanaka, Hideki Nakasone, Yuko Ishihara, Shinichi Kako, Seiichiro Kobayashi, Yuetsu Tanaka, Tsukasa Ohmori, Kaoru Uchimaru, Sachiko Okamoto, Junichi Mineno, Hiroshi Shiku, Satoshi Nishimura, Yoshinobu Kanda

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)

Article Oncology

CD4+ T cells support polyfunctionality of cytotoxic CD8+ T cells with memory potential in immunological control of tumor

Naoko Imai, Isao Tawara, Makiko Yamane, Daisuke Muraoka, Hiroshi Shiku, Hiroaki Ikeda

CANCER SCIENCE (2020)

Article Immunology

Relationship between T cell receptor clonotype and PD-1 expression of tumor-infiltrating lymphocytes in colorectal cancer

Kenta Sukegawa, Kiyomi Shitaoka, Hiroshi Hamana, Eiji Kobayashi, Yoshihiro Miyahara, Keisuke Fujii, Kei Tsuda, Shiori Saeki, Takuya Nagata, Tatsuhiko Ozawa, Shigeru Saito, Tsutomu Fujii, Atsushi Muraguchi, Hiroshi Shiku, Hiroyuki Kishi

EUROPEAN JOURNAL OF IMMUNOLOGY (2020)

Article Oncology

MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours

Mikiya Ishihara, Shinichi Kageyama, Yoshihiro Miyahara, Takeshi Ishikawa, Shugo Ueda, Norihito Soga, Hiroaki Naota, Katsumi Mukai, Naozumi Harada, Hiroaki Ikeda, Hiroshi Shiku

BMC CANCER (2020)

Article Cell Biology

Distinguishing functional exosomes and other extracellular vesicles as a nucleic acid cargo by the anion-exchange method

Naohiro Seo, Junko Nakamura, Tsuguhiro Kaneda, Hiroaki Tateno, Asako Shimoda, Takanori Ichiki, Koichi Furukawa, Jun Hirabayashi, Kazunari Akiyoshi, Hiroshi Shiku

Summary: The study proposes an effective method for preparing high-performance exosomes (EXOs) using an anion-exchange method. This method allows for the large-scale separation of bioactive EXOs and MV-like EVs, providing valuable insights for research on reliable bioactivity and drug discovery of extracellular vesicles.

JOURNAL OF EXTRACELLULAR VESICLES (2022)

Article Oncology

First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer

Hiroyasu Oda, Mikiya Ishihara, Yoshihiro Miyahara, Junko Nakamura, Yuji Kozuka, Motoh Iwasa, Akira Tsunoda, Yoshiki Yamashita, Kanako Saito, Toshiro Mizuno, Hiroshi Shiku, Naoyuki Katayama

CASE REPORTS IN ONCOLOGY (2019)

Meeting Abstract Biotechnology & Applied Microbiology

Novel DNA Vaccination Utilizing a Newly Developed Pyro-Drive Jet Injector (PJI) Induced Serological and Cellular Immune Responses Leading to In Vivo Suppression of Tumor Growth in a Rat Model

Yoshihiro Miyahara, Kunihiko Yamashita, Hiroshi Miyazaki, Linan Wang, Junko Nakamura, Makiko Yamane, Katsuya Miki, Hiroshi Shiku

MOLECULAR THERAPY (2019)

Article Hematology

Exosomal regulation of lymphocyte homing to the gut

Eun Jeong Park, Onmanee Prajuabjinda, Zay Yar Soe, Samuel Darkwah, Michael G. Appiah, Eiji Kawamoto, Fumiyasu Momose, Hiroshi Shiku, Motomu Shimaoka

BLOOD ADVANCES (2019)

Meeting Abstract Oncology

Immune sensitivity of tumor is governed by the mechanism for differentiation of tumor-associated macrophages (TAMs)

Daisuke Muraoka, Naohiro Seo, Tae Hayashi, Keisuke Fujii, Hiroaki Ikeda, Kazunari Akiyoshi, Naozumi Harada, Hiroshi Shiku

CANCER SCIENCE (2018)

Meeting Abstract Oncology

Two clinical trials of adoptive transfer of TCR-engineered T cells specific to MAGE-A4 and NY-ESO-1

Shinichi Kageyama, Mikiya Ishihara, Shigehisa Kitano, Yoshihiro Miyahara, Hidefumi Kato, Hideyuki Mishima, Noboru Yamamoto, Hiroaki Iwase, Hiroyoshi Hattori, Takeshi Funakoshi, Takashi Kojima, Takashi Watanabe, Hiroshi Shiku

CANCER SCIENCE (2018)

暂无数据